Mainz Biomed B.V. Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-26.3	-26.39	-11.69	-0.59	-0.96
Depreciation & Amortization	0.87	0.38	0.07	0.06	0.05
Share-Based Compensation	4.01	9.82	6.43	0	0
Other Operating Activities	-0.52	1.41	1.97	0.06	0.49
Operating Cash Flow	-21.94	-14.77	-3.22	-0.47	-0.42
Capital Expenditures	-1.9	-0.66	-0.02	-0.01	0
Acquisitions	0	0	1.22	0	0
Investing Cash Flow	-1.9	-0.66	1.2	-0.01	0
Share Issuance / Repurchase	6.39	23.87	10.43	0	0
Debt Issued / Paid	8.77	-0.3	-0.04	-0	0.42
Other Financing Activities	-0.93	0.38	0.22	0.4	-
Financing Cash Flow	14.23	23.94	10.61	0.4	0.42
Exchange Rate Effect	-0.46	-0.1	0.01	0	0
Net Cash Flow	-10.07	8.41	8.6	-0.08	0.01
Free Cash Flow	-23.84	-15.43	-3.24	-0.48	-0.42
Free Cash Flow Margin	-2662.00%	-2911.63%	-560.67%	-96.93%	-148.01%
Free Cash Flow Per Share	-1.47	-1.09	-0.45	-0.09	-0.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).